Abstract
Background: Previous trials have shown that digoxin is beneficial in subjects with heart failure (HF). However, these studies were conducted before the incorporation of beta-blockers as standard therapy for HF. There are limited data on the effect of digoxin in HF patients on a contemporary regimen of renin-angiotensin axis inhibitors and beta-blockers. Methods: 347 patients with HF admissions and depressed LV ejection fraction (LVEF), fulfilling Framingham criteria at the VA Hospital from 2002 to 2004 were analyzed according to use of digoxin at discharge.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
